{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:10:50Z","timestamp":1720397450624},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,7]]},"DOI":"10.7759\/cureus.64010","type":"journal-article","created":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T12:10:06Z","timestamp":1720354206000},"source":"Crossref","is-referenced-by-count":0,"title":["Ecstasy-Induced Rhabdomyolysis Leading to Severe Acute Kidney Injury Requiring Temporary Hemodialysis: A High Risk for Recurrence With Repeated Exposure"],"prefix":"10.7759","author":[{"given":"Sabastain F","family":"Forsah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibi","family":"Razak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divine Besong","family":"Arrey Agbor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnama","family":"Kouyate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Cossaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Dadlani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anum","family":"Humayun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-023-00526-1","article-title":"Illicit drug use in university students in the UK and Ireland: a PRISMA-guided scoping review","volume":"18","author":"Boden M","year":"2023","unstructured":"Boden M, Day E. Illicit drug use in university students in the UK and Ireland: a PRISMA-guided scoping review. Subst Abuse Treat Prev Policy. 2023, 18:18. 10.1186\/s13011-023-00526-1","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref2","article-title":"Ecstasy (MDMA) and its effects on kidneys and their treatment: a review","volume":"19","author":"Bora F","year":"2016","unstructured":"Bora F, Y\u0131lmaz F, Bora T. Ecstasy (MDMA) and its effects on kidneys and their treatment: a review. Iran J Basic Med Sci. 2016, 19:1151-8.","journal-title":"Iran J Basic Med Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02080508","article-title":"The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney","volume":"3","author":"Campbell GA","year":"2008","unstructured":"Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol. 2008, 3:1852-60. 10.2215\/CJN.02080508","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001188","article-title":"Prevalence and correlates of past year ecstasy\/MDMA use in the United States","volume":"17","author":"Yang KH","year":"2023","unstructured":"Yang KH, Kepner W, Nijum A, Han BH, Palamar JJ. Prevalence and correlates of past year ecstasy\/MDMA use in the United States. J Addict Med. 2023, 17:592-7. 10.1097\/ADM.0000000000001188","journal-title":"J Addict Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)02729-4","article-title":"Fatal uncertainty: death rate for use of ecstasy or heroin","volume":"354","author":"Gore SM","year":"1999","unstructured":"Gore SM. Fatal uncertainty: death rate for use of ecstasy or heroin. Lancet. 1999, 354:1265-6. 10.1016\/S0140-6736(99)02729-4","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael078","article-title":"Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management","volume":"96","author":"Hall AP","year":"2006","unstructured":"Hall AP, Henry JA. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. 2006, 96:678-85. 10.1093\/bja\/ael078","journal-title":"Br J Anaesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre R","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M, Roset PN, et al.. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit. 2004, 26:137-44. 10.1097\/00007691-200404000-00009","journal-title":"Ther Drug Monit"},{"key":"ref8","article-title":"Demystifying serotonin syndrome (or serotonin toxicity)","volume":"64","author":"Foong AL","year":"2018","unstructured":"Foong AL, Grindrod KA, Patel T, Kellar J. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician. 2018, 64:720-7.","journal-title":"Can Fam Physician"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4065\/76.1.112","article-title":"Delayed rhabdomyolysis after ecstasy use","volume":"76","author":"Halachanova V","year":"2001","unstructured":"Halachanova V, Sansone RA. McDonald S. . Elsevier Inc. volume 76, issue 1, P112-114 January 2001. Delayed rhabdomyolysis after ecstasy use. Mayo Clin Proc. 2001, 76:112-3. 10.4065\/76.1.112","journal-title":"Mayo Clin Proc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007182","article-title":"Rhabdomyolysis in community acquired bacterial sepsis--a retrospective cohort study","volume":"4","author":"Kumar AA","year":"2009","unstructured":"Kumar AA, Bhaskar E, Palamaner Subash Shantha G, Swaminathan P, Abraham G. Rhabdomyolysis in community acquired bacterial sepsis--a retrospective cohort study. PLoS One. 2009, 4:e7182. 10.1371\/journal.pone.0007182","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2021-000836","article-title":"Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document","volume":"7","author":"Kodadek L","year":"2022","unstructured":"Kodadek L, Carmichael Ii SP, Seshadri A, et al.. Rhabdomyolysis: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document. Trauma Surg Acute Care Open. 2022, 7:e000836. 10.1136\/tsaco-2021-000836","journal-title":"Trauma Surg Acute Care Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021842","article-title":"Protracted hyperthermia and delayed rhabdomyolysis in ecstasy toxicity: a case report","volume":"99","author":"Ghaffari-Rafi A","year":"2020","unstructured":"Ghaffari-Rafi A, Eum KS, Villanueva J, Jahanmir J. Protracted hyperthermia and delayed rhabdomyolysis in ecstasy toxicity: a case report. Medicine (Baltimore). 2020, 99:e21842. 10.1097\/MD.0000000000021842","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2016","article-title":"Rhabdomyolysis","volume":"144","author":"Zimmerman JL","year":"2013","unstructured":"Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013, 144:1058-65. 10.1378\/chest.12-2016","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(92)90237-r","article-title":"Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)","volume":"28","author":"Paris JM","year":"1992","unstructured":"Paris JM, Cunningham KA. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain Res Bull. 1992, 28:115-9. 10.1016\/0361-9230(92)90237-r","journal-title":"Brain Res Bull"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1081\/jdi-100103490","article-title":"Dialytic treatment of rhabdomyolysis-induced acute renal failure: our experience","volume":"23","author":"Splendiani G","year":"2001","unstructured":"Splendiani G, Mazzarella V, Cipriani S, Pollicita S, Rodio F, Casciani CU. Dialytic treatment of rhabdomyolysis-induced acute renal failure: our experience. Ren Fail. 2001, 23:183-91. 10.1081\/jdi-100103490","journal-title":"Ren Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271892-ecstasy-induced-rhabdomyolysis-leading-to-severe-acute-kidney-injury-requiring-temporary-hemodialysis-a-high-risk-for-recurrence-with-repeated-exposure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T12:10:14Z","timestamp":1720354214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271892-ecstasy-induced-rhabdomyolysis-leading-to-severe-acute-kidney-injury-requiring-temporary-hemodialysis-a-high-risk-for-recurrence-with-repeated-exposure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,7]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.64010","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,7]]}}}